Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02082301 · ClinicalTrials.gov registry record
Oral Glucose Tolerance Testing After Gestational Diabetes
A clinical trial of Obesity and Pregnancy, sponsored by MetroHealth Medical Center.
- Completed
- Registry status
- 118
- Enrollment target
- 2
- Study locations
NCT02082301: Completed study of Obesity and Pregnancy, sponsored by MetroHealth Medical Center.
NCT02082301 is a study of Obesity and Pregnancy that has completed, run by MetroHealth Medical Center. The registered enrollment target is 118 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02082301, a study of Obesity and Pregnancy, has completed, sponsored by MetroHealth Medical Center.
- COMPLETED
- Registry status
- 118 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an observation study of women with gestational diabetes. Subjects recruited undergo immediate postpartum diabetic screening prior to discharge. Post-partum screening for overt diabetes is repeated 6-12 weeks postpartum. The outcome of interest is the utility of an immediate post partum screen for overt diabetes compared to a traditional 6 week test.
Primary Outcome
2 hour fasting 75g OGTT immediately post partum. This is compared to a traditional 6 week post partum 75g OGTT for the sensitivity, positive and negative predictive value of the immediate post partum test
Conditions Studied
Study Locations (2)
Ohio
- University Hospital - Cleveland
- MetroHealth Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2012-10 |
| Est. Completion | 2019-12-31 |
What the finished NCT02082301 record still lists
NCT02082301 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT02082301 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02082301 about?
NCT02082301 is a clinical study titled "Oral Glucose Tolerance Testing After Gestational Diabetes". This is an observation study of women with gestational diabetes. Subjects recruited undergo immediate postpartum diabetic screening prior to discharge. Post-partum screening for overt diabetes is repeated 6-12 weeks postpartum. The outcome of interest is the utility of an immediate post partum scree...
What is the current status of trial NCT02082301?
This trial is currently completed. The enrollment target is 118 participants. The study started on 2012-10. Estimated completion is 2019-12-31.
What conditions does trial NCT02082301 study?
This clinical trial studies the following conditions: Obesity, Pregnancy, Gestational Diabetes.
Who is sponsoring clinical trial NCT02082301?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02082301 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02082301's enrollment target sits among peer trials
118 448th of 1053 higher than 606 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia